Work

Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer

Year: 2013

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdt489

Authors: C. Twelves, E. Chmielowska, L. Havel, S. Popat, A. Swieboda-Sadlej, P. Sawrycki, P. Bycott, A. Ingrosso, S. Kim, J.A. Williams, C. Chen, A.J. Olszanski, P. de Besi, J.H. Schiller

Institutions: Cancer Research UK, St James's University Hospital, Nicolaus Copernicus University, Fakultní nemocnice Bulovka, Royal Marsden Hospital, Central Clinical Hospital, Provincial Polyclinical Hospital in Toruń, Pfizer (United States), Fox Chase Cancer Center, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2053663663

FWCI: 4.879

Cites: 30

Cited by: 34

Related to: 10